Status:
COMPLETED
Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice
Lead Sponsor:
Pfizer
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and Qualit...
Eligibility Criteria
Inclusion
- Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
- Patients aged ≥ 18 years
- Moderate to severe PsA disease activity diagnosed
- Patients for whom the physician's decision has been made to initiate treatment with tofacitinib, in usual clinical practice conditions and in compliance with the local label
- Patients are treatment naïve to tofacitinib on the date of providing informed consent
- Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study
- Patients on DMARDs must have not had a treatment change in the past 3 months
Exclusion
- Patients meeting any of the following criteria will not be included in the study:
- Contraindications according to the Xeljanz® (tofacitinib) Prescribing Information
- Receipt of any investigational drug within 3 months before study inclusion
- Patient is pregnant or breastfeeding
- Recent herpes zoster infection (within past 6 months) or history of severe disseminated herpes zoster infection
- Active treatment for a malignancy
- Concomitant treatment with a biological disease-modifying antirheumatic drugs (bDMARD)
Key Trial Info
Start Date :
May 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04517669
Start Date
May 17 2021
End Date
July 30 2024
Last Update
October 14 2025
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Algemeen Stedelijk Ziekenhuis
Aalst, Belgium, 9300
2
AZ Sint-Jan
Bruges, Belgium, 8000
3
Nova Reuma Społka Partnerska
Genk, Belgium, 3600
4
Sygehus Vendsyssel Hospital
Hjørring, Denmark